• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型p53:多种机制决定癌症中的生物学活性。

Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer.

作者信息

Kim Michael Paul, Zhang Yun, Lozano Guillermina

机构信息

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA ; Department of Genetics, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.

Department of Genetics, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.

出版信息

Front Oncol. 2015 Nov 11;5:249. doi: 10.3389/fonc.2015.00249. eCollection 2015.

DOI:10.3389/fonc.2015.00249
PMID:26618142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4641161/
Abstract

The functional importance of p53 as a tumor suppressor gene is evident through its pervasiveness in cancer biology. The p53 gene is the most commonly altered gene in human cancer; however, not all genetic alterations are biologically equivalent. The majority of alterations involve p53 missense mutations that result in the production of mutant p53 proteins. Such mutant p53 proteins lack normal p53 function and may concomitantly gain novel functions, often with deleterious effects. Here, we review characterized mechanisms of mutant p53 gain of function in various model systems. In addition, we review mutant p53 addiction as emerging evidence suggests that tumors may depend on sustained mutant p53 activity for continued growth. We also discuss the role of p53 in stromal elements and their contribution to tumor initiation and progression. Lastly, current genetic mouse models of mutant p53 in various organ systems are reviewed and their limitations discussed.

摘要

p53作为一种肿瘤抑制基因的功能重要性,通过其在癌症生物学中的普遍性得以体现。p53基因是人类癌症中最常发生改变的基因;然而,并非所有的基因改变在生物学上都是等同的。大多数改变涉及p53错义突变,这些突变导致突变型p53蛋白的产生。此类突变型p53蛋白缺乏正常p53功能,并且可能同时获得新功能,通常具有有害影响。在此,我们综述了各种模型系统中已明确的突变型p53功能获得机制。此外,鉴于新出现的证据表明肿瘤可能依赖持续的突变型p53活性来持续生长,我们对突变型p53成瘾现象进行了综述。我们还讨论了p53在基质成分中的作用及其对肿瘤起始和进展的贡献。最后,我们综述了目前各种器官系统中突变型p53的基因小鼠模型,并讨论了它们的局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f22/4641161/14e86de57f3f/fonc-05-00249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f22/4641161/14e86de57f3f/fonc-05-00249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f22/4641161/14e86de57f3f/fonc-05-00249-g001.jpg

相似文献

1
Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer.突变型p53:多种机制决定癌症中的生物学活性。
Front Oncol. 2015 Nov 11;5:249. doi: 10.3389/fonc.2015.00249. eCollection 2015.
2
Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.人类乳腺癌中突变型p53的积累并非内在特性,也不依赖于结构或功能破坏,而是受外源性应激和受体状态调控。
J Pathol. 2014 Jul;233(3):238-46. doi: 10.1002/path.4356. Epub 2014 May 21.
3
Mutant p53 in colon cancer.结肠癌中的突变型 p53。
J Mol Cell Biol. 2019 Apr 1;11(4):267-276. doi: 10.1093/jmcb/mjy075.
4
Mutant p53: One, No One, and One Hundred Thousand.突变型p53:一、无人、十万
Front Oncol. 2015 Dec 21;5:289. doi: 10.3389/fonc.2015.00289. eCollection 2015.
5
Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.突变型p53通过获得与复杂腺管形成相关的侵袭性促进肠道癌进展。
Oncogene. 2017 Oct 19;36(42):5885-5896. doi: 10.1038/onc.2017.194. Epub 2017 Jun 19.
6
Complexes formed by mutant p53 and their roles in breast cancer.由突变型p53形成的复合物及其在乳腺癌中的作用。
Breast Cancer (Dove Med Press). 2018 Jun 18;10:101-112. doi: 10.2147/BCTT.S145826. eCollection 2018.
7
Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.抑制葡糖神经酰胺合酶可消除p53 R273H突变体在上皮-间质转化及诱导结肠癌细胞多能性中的致癌功能。
Oncotarget. 2016 Sep 13;7(37):60575-60592. doi: 10.18632/oncotarget.11169.
8
[Advances on mutant p53 research].[突变型p53研究进展]
Yi Chuan. 2008 Jun;30(6):697-703. doi: 10.3724/sp.j.1005.2008.00697.
9
p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo.p53杂合性缺失是体内突变型p53稳定及功能获得的必要前提条件。
Cell Death Dis. 2017 Mar 9;8(3):e2661. doi: 10.1038/cddis.2017.80.
10
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.p53功能获得性癌症突变体通过使ATM失活诱导基因不稳定。
Nat Cell Biol. 2007 May;9(5):573-80. doi: 10.1038/ncb1571. Epub 2007 Apr 8.

引用本文的文献

1
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer.靶向巨噬细胞移动抑制因子作为结直肠癌的一种潜在治疗策略。
Oncogenesis. 2025 Aug 20;14(1):30. doi: 10.1038/s41389-025-00572-3.
2
Phage libraries screening on P53: Yield improvement by zinc and a new parasites-integrating analysis.基于 P53 的噬菌体文库筛选:锌的产量提高和一种新的寄生虫整合分析。
PLoS One. 2024 Oct 3;19(10):e0297338. doi: 10.1371/journal.pone.0297338. eCollection 2024.
3
Decoding the molecular symphony: interactions between the mA and p53 signaling pathways in cancer.

本文引用的文献

1
Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.削弱人类癌症中的p53信号通路:殊途同归
Cold Spring Harb Perspect Med. 2016 Aug 1;6(8):a026211. doi: 10.1101/cshperspect.a026211.
2
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.功能获得性p53突变体利用染色质途径来驱动癌症生长。
Nature. 2015 Sep 10;525(7568):206-11. doi: 10.1038/nature15251. Epub 2015 Sep 2.
3
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.通过利用肿瘤对稳定的突变型p53的依赖性进行治疗来提高生存率。
解码分子交响曲:癌症中mA与p53信号通路之间的相互作用
NAR Cancer. 2024 Sep 26;6(3):zcae037. doi: 10.1093/narcan/zcae037. eCollection 2024 Sep.
4
Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications.乳腺癌中调控M2巨噬细胞侵袭和迁移的基因表达预测模型:临床预后及治疗意义
Transl Cancer Res. 2024 Aug 31;13(8):4187-4204. doi: 10.21037/tcr-24-29. Epub 2024 Aug 21.
5
Delineating the mechanistic relevance of the gene and its mutational impact on gene expression and patients' survival in bladder cancer.阐明该基因的机制相关性及其突变对膀胱癌基因表达和患者生存的影响。
Heliyon. 2024 May 15;10(10):e31286. doi: 10.1016/j.heliyon.2024.e31286. eCollection 2024 May 30.
6
Somatic alterations of and associated with response to enfortumab vedotin in patients with advanced urothelial cancer.晚期尿路上皮癌患者中与对恩杂鲁胺治疗反应相关的[具体基因名称]和[具体基因名称]的体细胞改变。 (你提供的原文中“and”前后的内容缺失,请补充完整以便更准确翻译)
Front Oncol. 2023 Apr 5;13:1161089. doi: 10.3389/fonc.2023.1161089. eCollection 2023.
7
DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen.通过虚拟筛选鉴定出的一种新型化合物对DNAJA1和构象突变型p53依赖性癌细胞迁移的抑制作用。
Cell Death Discov. 2022 Oct 31;8(1):437. doi: 10.1038/s41420-022-01229-5.
8
Anti-cancer properties of by altering expression of Bcl-2, BAX, cleaved caspase 3 and apoptosis in HeLa cancer cell culture.通过改变HeLa癌细胞培养中Bcl-2、BAX、裂解的半胱天冬酶3的表达及细胞凋亡来发挥抗癌特性。 (注:原文by前少内容,翻译时进行了补充以使句子完整通顺)
Front Oncol. 2022 Sep 20;12:964816. doi: 10.3389/fonc.2022.964816. eCollection 2022.
9
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine.伴有或不伴有 TP53 突变的不良细胞遗传学患者接受 Venetoclax 和阿扎胞苷治疗的结局。
Clin Cancer Res. 2022 Dec 15;28(24):5272-5279. doi: 10.1158/1078-0432.CCR-22-1183.
10
Li-Fraumeni Syndrome: Mutation of Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment.李-弗劳梅尼综合征: 是肿瘤遗传性易感性的生物标志物突变:治疗的新见解与进展
Cancers (Basel). 2022 Jul 27;14(15):3664. doi: 10.3390/cancers14153664.
Nature. 2015 Jul 16;523(7560):352-6. doi: 10.1038/nature14430. Epub 2015 May 25.
4
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.胰腺癌的全外显子组测序确定了基因多样性和治疗靶点。
Nat Commun. 2015 Apr 9;6:6744. doi: 10.1038/ncomms7744.
5
Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells.单细胞RNA测序可识别胰腺循环肿瘤细胞的细胞外基质基因表达。
Cell Rep. 2014 Sep 25;8(6):1905-1918. doi: 10.1016/j.celrep.2014.08.029. Epub 2014 Sep 18.
6
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.磷脂酶Pla2g16介导突变型p53的功能获得性活性。
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11145-50. doi: 10.1073/pnas.1404139111. Epub 2014 Jul 14.
7
Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation.通过稳定突变型 p53 蛋白组学和转化为 WT 构象来挽救细胞转化中的胚胎干细胞。
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7006-11. doi: 10.1073/pnas.1320428111. Epub 2014 Apr 28.
8
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling.突变型 p53 通过细胞自主 PDGF 受体 β 信号促进胰腺癌转移。
Cell. 2014 Apr 10;157(2):382-394. doi: 10.1016/j.cell.2014.01.066.
9
Non-cell-autonomous tumor suppression by p53.p53 非细胞自主的肿瘤抑制作用。
Cell. 2013 Apr 11;153(2):449-60. doi: 10.1016/j.cell.2013.03.020. Epub 2013 Apr 4.
10
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.利用 cBioPortal 进行复杂癌症基因组学和临床特征的综合分析
Sci Signal. 2013 Apr 2;6(269):pl1. doi: 10.1126/scisignal.2004088.